share_log

Teladoc Health Analyst Ratings

Benzinga ·  Oct 25, 2023 09:43
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/25/2023 54.76% Oppenheimer $35 → $26 Maintains Outperform
10/23/2023 25% Citigroup $29 → $21 Maintains Neutral
10/20/2023 25% Citigroup $29 → $21 Maintains Neutral
09/25/2023 66.67% Truist Securities → $28 Reiterates Hold → Hold
07/26/2023 66.67% Stephens & Co. → $28 Reiterates Equal-Weight → Equal-Weight
07/26/2023 108.33% RBC Capital → $35 Reiterates Outperform → Outperform
07/26/2023 72.62% Citigroup $31 → $29 Maintains Neutral
07/26/2023 60.71% Credit Suisse → $27 Reiterates Neutral → Neutral
04/28/2023 72.62% Deutsche Bank $27 → $29 Maintains Hold
04/27/2023 84.52% Citigroup $30 → $31 Maintains Neutral
04/27/2023 108.33% RBC Capital → $35 Reiterates → Outperform
04/27/2023 60.71% Credit Suisse → $27 Reiterates → Neutral
04/27/2023 72.62% Barclays $28 → $29 Maintains Equal-Weight
04/12/2023 48.81% Stephens & Co. → $25 Initiates Coverage On → Equal-Weight
03/10/2023 60.71% Credit Suisse $30 → $27 Maintains Neutral
03/06/2023 114.29% Canaccord Genuity $40 → $36 Maintains Buy
03/06/2023 36.9% Wells Fargo $28 → $23 Maintains Equal-Weight
02/28/2023 78.57% Citigroup $33 → $30 Maintains Neutral
02/27/2023 60.71% Deutsche Bank $31 → $27 Maintains Hold
02/27/2023 96.43% JP Morgan $35 → $33 Maintains Neutral
02/23/2023 108.33% Oppenheimer $37 → $35 Maintains Outperform
02/23/2023 108.33% RBC Capital → $35 Reiterates → Outperform
02/23/2023 102.38% SVB Leerink → $34 Upgrades Market Perform → Outperform
01/19/2023 120.24% Oppenheimer $45 → $37 Maintains Outperform
01/18/2023 66.67% Barclays $32 → $28 Maintains Equal-Weight
12/13/2022 96.43% Citigroup $36 → $33 Maintains Neutral
10/31/2022 78.57% Credit Suisse $35 → $30 Maintains Neutral
10/27/2022 114.29% Citigroup $38 → $36 Maintains Neutral
10/27/2022 90.48% Barclays $33 → $32 Maintains Equal-Weight
10/25/2022 138.1% DA Davidson $45 → $40 Maintains Buy
10/24/2022 Guggenheim Upgrades Sell → Neutral
10/21/2022 72.62% Truist Securities $35 → $29 Maintains Hold
10/11/2022 96.43% Barclays $40 → $33 Maintains Equal-Weight
09/28/2022 108.33% RBC Capital $53 → $35 Maintains Outperform
09/27/2022 84.52% Deutsche Bank $34 → $31 Maintains Hold
09/16/2022 Keybanc Initiates Coverage On → Sector Weight
09/07/2022 108.33% Truist Securities → $35 Initiates Coverage On → Hold
08/17/2022 48.81% Guggenheim → $25 Downgrades Neutral → Sell
08/12/2022 167.86% DA Davidson → $45 Initiates Coverage On → Buy
08/02/2022 108.33% Berenberg $42 → $35 Downgrades Buy → Hold
08/02/2022 102.38% Cowen & Co. $58 → $34 Downgrades Outperform → Market Perform
07/28/2022 114.29% Goldman Sachs $55 → $36 Downgrades Buy → Neutral
07/28/2022 138.1% Barclays $42 → $40 Maintains Equal-Weight
07/28/2022 Needham Downgrades Buy → Hold
07/28/2022 138.1% Piper Sandler $42 → $40 Maintains Overweight
07/28/2022 227.38% Oppenheimer $65 → $55 Maintains Outperform
07/28/2022 102.38% SVB Leerink $35 → $34 Maintains Market Perform
07/20/2022 150% Barclays $45 → $42 Maintains Equal-Weight
06/29/2022 114.29% Stifel $45 → $36 Maintains Hold
05/26/2022 227.38% Goldman Sachs $77 → $55 Maintains Buy
05/05/2022 Argus Research Downgrades Buy → Hold
04/28/2022 78.57% Craig-Hallum $67 → $30 Maintains Hold
04/28/2022 197.62% Canaccord Genuity $112 → $50 Maintains Buy
04/28/2022 161.9% Deutsche Bank $78 → $44 Maintains Hold
04/28/2022 286.9% RBC Capital $120 → $65 Maintains Outperform
04/28/2022 Guggenheim Downgrades Buy → Neutral
04/28/2022 155.95% Citigroup $115 → $43 Downgrades Buy → Neutral
04/28/2022 138.1% Wells Fargo → $40 Downgrades Overweight → Equal-Weight
04/28/2022 108.33% Credit Suisse $114 → $35 Downgrades Outperform → Neutral
04/28/2022 185.71% Needham $100 → $48 Maintains Buy
04/28/2022 108.33% SVB Leerink $161 → $35 Downgrades Outperform → Market Perform
04/28/2022 William Blair Downgrades Outperform → Market Perform
04/12/2022 614.29% RBC Capital $215 → $120 Maintains Outperform
04/07/2022 471.43% Guggenheim → $96 Initiates Coverage On → Buy
03/08/2022 519.05% Piper Sandler $108 → $104 Maintains Overweight
03/08/2022 328.57% UBS $130 → $72 Maintains Neutral
03/03/2022 465.48% Argus Research → $95 Upgrades Hold → Buy
02/25/2022 578.57% Credit Suisse $151 → $114 Maintains Outperform
02/24/2022 364.29% Deutsche Bank $81 → $78 Maintains Hold
02/23/2022 673.81% Oppenheimer $160 → $130 Maintains Outperform
02/23/2022 298.81% Craig-Hallum $82 → $67 Maintains Hold
02/23/2022 340.48% Stifel $83 → $74 Maintains Hold
02/23/2022 644.05% JP Morgan $208 → $125 Maintains Overweight
02/23/2022 495.24% Needham $170 → $100 Maintains Buy
02/23/2022 358.33% Barclays $95 → $77 Maintains Equal-Weight
02/23/2022 495.24% Keybanc $180 → $100 Maintains Overweight
02/23/2022 858.33% SVB Leerink $193 → $161 Maintains Outperform
02/11/2022 620.24% Goldman Sachs → $121 Initiates Coverage On → Buy
02/07/2022 388.1% Jefferies $113 → $82 Maintains Hold
01/25/2022 382.14% Deutsche Bank $163 → $81 Maintains Hold
11/23/2021 852.38% Canaccord Genuity $188 → $160 Maintains Buy
11/22/2021 BTIG Downgrades Buy → Neutral
11/19/2021 941.67% Citigroup $190 → $175 Maintains Buy
11/19/2021 1132.14% Credit Suisse $208 → $207 Maintains Outperform
11/19/2021 1001.19% Oppenheimer $200 → $185 Maintains Outperform
11/19/2021 703.57% Stephens & Co. $140 → $135 Maintains Equal-Weight
11/19/2021 1048.81% SVB Leerink $205 → $193 Maintains Outperform
11/15/2021 1179.76% RBC Capital $260 → $215 Maintains Outperform
10/29/2021 882.14% Wells Fargo $156 → $165 Maintains Overweight
10/28/2021 792.86% Barclays $170 → $150 Maintains Equal-Weight
10/28/2021 1090.48% Oppenheimer $220 → $200 Maintains Outperform
10/28/2021 911.9% Needham $205 → $170 Maintains Buy
10/28/2021 1120.24% SVB Leerink $218 → $205 Maintains Outperform
10/19/2021 828.57% Wells Fargo → $156 Initiates Coverage On → Overweight
08/09/2021 1019.05% Cowen & Co. $240 → $188 Maintains Outperform
08/02/2021 Argus Research Downgrades Buy → Hold
07/28/2021 810.71% Deutsche Bank $225 → $153 Downgrades Buy → Hold
07/28/2021 1209.52% Oppenheimer $250 → $220 Maintains Outperform
07/28/2021 1120.24% Needham $235 → $205 Maintains Buy
07/28/2021 1197.62% SVB Leerink $266 → $218 Maintains Outperform
07/28/2021 971.43% Keybanc $220 → $180 Maintains Overweight
05/28/2021 864.29% Baird → $162 Initiates Coverage On → Neutral
04/30/2021 1471.43% Credit Suisse $300 → $264 Maintains Outperform
04/29/2021 1655.95% Canaccord Genuity $330 → $295 Maintains Buy
04/29/2021 1685.71% BTIG $330 → $300 Maintains Buy
04/29/2021 1209.52% Keybanc $270 → $220 Maintains Overweight
04/15/2021 1298.81% Needham → $235 Initiates Coverage On → Buy
03/17/2021 1245.24% Deutsche Bank $263 → $226 Maintains Buy
02/26/2021 1685.71% Credit Suisse $296 → $300 Maintains Outperform
02/25/2021 1536.9% DA Davidson $260 → $275 Maintains Buy
02/25/2021 1507.14% Oppenheimer $250 → $270 Maintains Outperform
02/25/2021 1376.19% Jefferies $264 → $248 Maintains Hold
02/25/2021 1465.48% Deutsche Bank $244 → $263 Maintains Buy
02/25/2021 1632.14% Piper Sandler $305 → $291 Maintains Overweight
02/25/2021 1483.33% SVB Leerink $256 → $266 Maintains Outperform
02/25/2021 1507.14% Keybanc $245 → $270 Maintains Overweight
01/07/2021 1328.57% BTIG → $240 Initiates Coverage On → Buy
12/22/2020 1179.76% Evercore ISI Group → $215 Initiates Coverage On → In-Line
12/07/2020 Stephens & Co. Downgrades Overweight → Equal-Weight
12/04/2020 1126.19% Goldman Sachs → $206 Initiates Coverage On → Neutral
11/13/2020 1209.52% Baird → $220 Upgrades Neutral → Outperform
10/29/2020 1352.38% Deutsche Bank $239 → $244 Maintains Buy
10/29/2020 1090.48% Wells Fargo $175 → $200 Maintains Equal-Weight
10/29/2020 1453.57% Canaccord Genuity $255 → $261 Maintains Buy
10/29/2020 1423.81% SVB Leerink $246 → $256 Maintains Outperform
10/29/2020 1358.33% Keybanc $240 → $245 Maintains Overweight
09/22/2020 1388.1% DA Davidson → $250 Initiates Coverage On → Buy
08/17/2020 1382.14% Credit Suisse $225 → $249 Upgrades Neutral → Outperform
07/30/2020 1280.95% Piper Sandler $220 → $232 Maintains Overweight
07/30/2020 1120.24% Stifel $144 → $205 Maintains Hold
07/30/2020 1417.86% Canaccord Genuity $195 → $255 Maintains Buy
07/30/2020 1316.67% Deutsche Bank $184 → $238 Maintains Buy
07/30/2020 1298.81% RBC Capital $200 → $235 Maintains Outperform
07/30/2020 1364.29% SVB Leerink $227 → $246 Maintains Outperform
07/30/2020 1328.57% Keybanc $195 → $240 Maintains Overweight
07/13/2020 1566.67% Argus Research → $280 Initiates Coverage On → Buy
07/06/2020 1251.19% SVB Leerink $197 → $227 Maintains Outperform
06/05/2020 1209.52% Piper Sandler $212 → $220 Maintains Overweight
05/13/2020 1090.48% SunTrust Robinson Humphrey $144 → $200 Maintains Hold
04/30/2020 1060.71% Canaccord Genuity $130 → $195 Maintains Buy
04/30/2020 1001.19% UBS $119 → $185 Maintains Neutral
04/30/2020 757.14% Stifel $135 → $144 Maintains Hold
04/30/2020 882.14% Credit Suisse $152 → $165 Maintains Neutral
04/30/2020 1072.62% SVB Leerink $180 → $197 Reiterates → Outperform
04/30/2020 1060.71% Keybanc $180 → $195 Maintains Overweight
04/16/2020 703.57% Wells Fargo $105 → $135 Maintains Equal-Weight
04/15/2020 763.1% Cantor Fitzgerald $135 → $145 Maintains Neutral
04/15/2020 941.67% Cowen & Co. $150 → $175 Maintains Outperform
04/15/2020 1048.81% Piper Sandler $142 → $193 Maintains Overweight
04/15/2020 923.81% Deutsche Bank $179 → $172 Maintains Buy
04/15/2020 703.57% Baird $130 → $135 Maintains Neutral
04/15/2020 971.43% Keybanc $145 → $180 Maintains Overweight
04/15/2020 983.33% JP Morgan $164 → $182 Maintains Overweight
04/06/2020 804.76% Credit Suisse $137 → $152 Maintains Neutral
04/02/2020 965.48% Deutsche Bank $194 → $179 Maintains Buy
03/31/2020 Berenberg Downgrades Buy → Hold
03/26/2020 602.38% SunTrust Robinson Humphrey $110 → $118 Maintains Hold
03/24/2020 1042.86% Deutsche Bank $142 → $192 Maintains Buy
03/16/2020 763.1% Keybanc → $145 Upgrades Sector Weight → Overweight
03/12/2020 673.81% Baird → $130 Downgrades Outperform → Neutral
03/06/2020 715.48% Credit Suisse $111 → $137 Maintains Neutral
02/28/2020 Keybanc Downgrades Overweight → Sector Weight
02/27/2020 745.24% Piper Sandler $87 → $142 Reiterates → Overweight
02/27/2020 560.71% Credit Suisse $90 → $111 Maintains Neutral
02/27/2020 745.24% Deutsche Bank $101 → $142 Maintains Buy
02/27/2020 769.05% JP Morgan $112 → $146 Reiterates → Overweight
02/27/2020 554.76% Stifel $83 → $110 Maintains Hold
02/27/2020 733.33% B of A Securities $106 → $140 Reiterates → Neutral
02/27/2020 608.33% UBS $90 → $119 Maintains Neutral
02/27/2020 703.57% Cantor Fitzgerald $72 → $135 Reiterates → Neutral
02/12/2020 525% Wells Fargo → $105 Downgrades Overweight → Equal-Weight
01/24/2020 530.95% B of A Securities $90 → $106 Reiterates → Neutral
01/21/2020 554.76% RBC Capital $100 → $110 Maintains Outperform
01/14/2020 465.48% Barclays $80 → $95 Maintains Equal-Weight
01/14/2020 530.95% Keybanc $93 → $106 Maintains Overweight
01/13/2020 495.24% Cowen & Co. $86 → $100 Maintains Outperform
01/10/2020 435.71% UBS → $90 Initiates Coverage On → Neutral
01/09/2020 435.71% B of A Securities $82 → $90 Downgrades Buy → Neutral
01/08/2020 465.48% Wells Fargo $77 → $95 Maintains Overweight
12/18/2019 411.9% Keybanc $75 → $86 Maintains Overweight
12/13/2019 376.19% Barclays → $80 Initiates Coverage On → Equal-Weight
12/06/2019 Jefferies Downgrades Buy → Hold
12/02/2019 376.19% SunTrust Robinson Humphrey → $80 Downgrades Buy → Hold
11/25/2019 394.05% Stifel → $83 Initiates Coverage On → Hold
11/22/2019 495.24% RBC Capital → $100 Initiates Coverage On → Outperform
11/04/2019 352.38% Credit Suisse $67 → $76 Maintains Neutral
09/19/2019 394.05% JP Morgan $82 → $83 Reiterates → Overweight
09/12/2019 352.38% Deutsche Bank → $76 Initiates Coverage On → Buy
06/13/2019 B of A Securities Initiates Coverage On → Buy
04/18/2019 Guggenheim Initiates Coverage On → Buy
04/17/2019 346.43% Stephens & Co. → $75 Initiates Coverage On → Overweight
02/28/2019 316.67% Cantor Fitzgerald $83 → $70 Maintains Neutral
01/31/2019 Berenberg Initiates Coverage On → Buy
01/14/2019 376.19% Baird → $80 Upgrades Neutral → Outperform

What is the target price for Teladoc Health (TDOC)?

The latest price target for Teladoc Health (NYSE: TDOC) was reported by Oppenheimer on October 25, 2023. The analyst firm set a price target for $26.00 expecting TDOC to rise to within 12 months (a possible 54.76% upside). 29 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Teladoc Health (TDOC)?

The latest analyst rating for Teladoc Health (NYSE: TDOC) was provided by Oppenheimer, and Teladoc Health maintained their outperform rating.

When is the next analyst rating going to be posted or updated for Teladoc Health (TDOC)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Teladoc Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Teladoc Health was filed on October 25, 2023 so you should expect the next rating to be made available sometime around October 25, 2024.

Is the Analyst Rating Teladoc Health (TDOC) correct?

While ratings are subjective and will change, the latest Teladoc Health (TDOC) rating was a maintained with a price target of $35.00 to $26.00. The current price Teladoc Health (TDOC) is trading at is $16.80, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment